Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02444169 · ClinicalTrials.gov registry record
Retrospective Evaluation of Combination Treatment With the Ulthera System
A clinical trial, sponsored by Ulthera.
- Completed
- Registry status
- 101
- Enrollment target
NCT02444169 is a clinical trial that has completed, run by Ulthera. The registered enrollment target is 101 participants.
The verdict
NCT02444169 has completed, sponsored by Ulthera.
- COMPLETED
- Registry status
- 101 participants
- Enrollment target
Study Summary
A retrospective study to evaluate the Ulthera® System for its potential interaction with toxins and fillers. Up to 500 subjects will be enrolled.
Interventions
- DEVICE Radiesse
- DEVICE Ultherapy
- DRUG Incobotulinumtoxin A
- DEVICE Belotero Balance
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 101 participants |
| Start Date | 2015-04 |
| Est. Completion | 2015-07 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02444169
The ClinicalTrials.gov registry entry for NCT02444169 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 101 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Ulthera, which has 42 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which Radiesse is the first listed.
NCT02444169 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02444169 about?
NCT02444169 is a clinical study titled "Retrospective Evaluation of Combination Treatment With the Ulthera System". A retrospective study to evaluate the Ulthera® System for its potential interaction with toxins and fillers. Up to 500 subjects will be enrolled.
What is the current status of trial NCT02444169?
This trial is currently completed. The enrollment target is 101 participants. The study started on 2015-04. Estimated completion is 2015-07.
What interventions are being tested in trial NCT02444169?
The interventions under investigation include: Radiesse (DEVICE), Ultherapy (DEVICE), Incobotulinumtoxin A (DRUG), Belotero Balance (DEVICE).
Who is sponsoring clinical trial NCT02444169?
This trial is sponsored by Ulthera, which has 42 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.